4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-059526
CEO sold 150,000 shares at an average $52.34 ($7,851,300)
- CEO acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2019-12-05 | Option exercise | +150,000 | $19.65 | $2,947,500 | 152,954 | D |
| DAVIS STEPHEN CEO | 2019-12-05 | Sale | −81,585 | $52.82 | $4,309,320 | 71,369 | D |
| DAVIS STEPHEN CEO | 2019-12-05 | Sale | −40,159 | $52.09 | $2,091,882 | 31,210 | D |
| DAVIS STEPHEN CEO | 2019-12-05 | Sale | −28,256 | $51.32 | $1,450,098 | 2,954 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2019-12-05 | Option exercise · Stock Option (Right to Buy) | −150,000 | 300,000 | D | ||
| Open-market sales · 150,000 sh · avg $52.34 · $7,851,300 | |||||||
Loading xslF345X03/doc4.xml…